Course / Criticisms of PGT-A
Although PGT-A is widely marketed as a major advancement in IVF success rates, not all experts agree on its overall benefits. Concerns exist regarding its accuracy, cost-effectiveness, and impact on viable embryos.
Understanding these criticisms allows for more informed decision-making, especially when weighing the benefits versus the potential risks.
The process of obtaining cells for PGT-A involves removing several trophectoderm cells from the embryo’s outer layer.
While this technique is considered safe in experienced hands, it is not entirely risk-free.
Potential risks include:
Cell damage that could compromise embryo viability.
Embryo loss during or after biopsy.
Developmental disruption due to manipulation at the blastocyst stage.
Modern techniques have minimized these risks, but the criticism remains valid: any invasive manipulation can theoretically reduce the embryo’s potential for successful implantation.
Another major concern revolves around testing accuracy.
PGT-A examines a few cells from the trophectoderm, assuming they represent the entire embryo’s chromosomal status. However, genetic variability (mosaicism) can lead to false positives—labeling healthy embryos as abnormal.
Consequently, embryos that might have developed into healthy babies may be discarded based on incomplete or misleading results.
For older patients, who often produce fewer embryos, discarding any embryo based on potentially unreliable testing can reduce their chances of pregnancy.
While PGT-A is designed to identify chromosomally normal embryos, it may actually decrease the total number of transferable embryos for women over 38.
Critics argue that in this population, the risk of losing a potentially viable embryo outweighs the benefits of genetic screening.
Younger women generally have a higher proportion of chromosomally normal embryos.
In this group, PGT-A often adds cost without significantly improving success rates.
Because the likelihood of finding aneuploid embryos is low, the testing may provide limited clinical advantage, and the financial investment may not be justified.
Some experts claim that PGT-A has been overpromoted as a guaranteed solution for miscarriage prevention and IVF success.
While it can reduce the risk of transferring chromosomally abnormal embryos, it does not guarantee pregnancy or eliminate all causes of implantation failure.
Furthermore, data supporting improved live birth rates with PGT-A are mixed—benefits are often case-specific rather than universal.
The financial aspect is one of the strongest practical criticisms.
PGT-A can add $3,000–$6,000 or more to an IVF cycle.
If the benefit is uncertain—particularly for younger or lower-risk patients—critics question whether the test justifies its cost.
Clinics and patients must carefully assess whether PGT-A offers measurable value in each individual situation.
Individualize PGT-A use — Not every patient benefits. Decisions should depend on age, embryo count, and reproductive history.
Discuss mosaicism results carefully — Some embryos labeled as “abnormal” may still have potential for healthy development.
Choose experienced labs — The skill and validation protocols of your genetic testing laboratory greatly influence accuracy.
Seek expert counseling — A reproductive genetic counselor can help interpret complex PGT-A results before any embryo is discarded.
Weigh clinical context over marketing claims — PGT-A is a tool, not a guarantee. Its value depends on thoughtful, case-by-case application.
Talk with our physician-led team about your family, embryos, timeline and budget. We’ll explain your options and next steps with no obligation.
Our job is to listen, to connect the dots between your needs, and to determine how we can best help you have your baby. If you’re asking how much does it cost for a surrogate, we’ll walk you through every step of the process to ensure there are no surprises.
To make an appointment with one of our counselors or physicians, please call (212) 661-7673 or email info@surrogacy4all.com. We look forward to hearing from you.
Since 2006, Surrogacy4All has helped intended parents in the United States and around the world build their families through physician-led gestational surrogacy and egg donation.
Secret Guide to Minimizing Surrogacy Costs
NYS Surrogacy Program License GSP220903 · NYS Tissue Bank License ID 1570 · California Tissue Bank License CTB00082276 · Maryland Tissue Bank License TB3527 · FDA HCT/P Establishment Registration FEI 3021544308 · Health Canada Establishment Registration 000119 Verify: How to check our licenses
THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE AND MAY BE OUT OF DATE. The information, including but not limited to text, PDFs, graphics, images, and other material contained on this website, is for general educational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment, and does not create a patient-doctor relationship. Pricing on the website may be out of date, is subject to change without notice, and may be subject to additional terms and conditions. No information on this site is intended to be a financial quote for medical services. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition, lifestyle or dietary changes, treatments, and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Licensed & Registered: NYS Surrogacy Program License GSP220903 · NYS Tissue Bank License ID 1570 · California Tissue Bank License CTB00082276 · Maryland Tissue Bank License TB3527 · FDA HCT/P Establishment Registration FEI 3021544308 · Health Canada Establishment Registration 000119
Verify: How to check our licenses
Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE AND MAY BE OUT OF DATE. The information, including but not limited to text, PDFs, graphics, images, and other material contained on this website, is for general educational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment, and does not create a patient-doctor relationship. Pricing on the website may be out of date, is subject to change without notice, and may be subject to additional terms and conditions. No information on this site is intended to be a financial quote for medical services. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition, lifestyle or dietary changes, treatments, and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
All Rights Reserved to Surrogacy4all
RESOLVE: The National Infertility Association, established in 1974, is dedicated to ensuring that all people challenged in their family building journey reach resolution through being empowered by knowledge, supported by community, united by advocacy, and inspired to act.
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers.
Welcome to the Parent Guide: Starting Life Together, for children and their caregivers. Whether you are a mother or father (through birth, adoption, or foster care), a grandparent, partner, family friend, aunt or uncle with parenting responsibilities, the Parent Guide has information to help you through the FIRST FIVE YEARS of your parenting journey.
Path2Parenthood (P2P) is an inclusive organization committed to helping people create their families of choice by providing leading-edge outreach programs.
The FDA is a part of the Department of Health and Human Services.
Each day in America, you can trust the foods you eat and the medicines you take, thanks to the U.S. Food and Drug Administration.